Cell-based vaccines for the stimulation of immunity to metastatic cancers

被引:47
|
作者
Ostrand-Rosenberg, S [1 ]
Pulaski, BA [1 ]
Clements, VK [1 ]
Qi, L [1 ]
Pipeling, MR [1 ]
Hanyok, LA [1 ]
机构
[1] Univ Maryland, Dept Sci Biol, Baltimore, MD 21250 USA
关键词
D O I
10.1111/j.1600-065X.1999.tb01332.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We are developing vaccines for inducing immunity to metastatic cancers. Although primary tumors are frequently cured by surgery, chemotherapy, or radiation therapy, metastatic lesions often do not respond to these treatments or proliferate after conventional therapy is terminated. Vaccine therapy for established metastases as well as prophylactic vaccine treatment to prevent outgrowth of latent metastatic tumor cells would therefore be beneficial. Our goal is to activate CD4(+) and CD8(+) T lymphocytes; however, we have focused on activating tumor-specific CD4(+) T-helper lymphocytes because of their pivotal role as regulatory cells and in the generation of long-term immunological memory. The vaccines are based on the premise that tumor cells express potentially immunogenic antigens that could be targeted for T-cell activation, and that if appropriately genetically modified, tumor cells could be antigen presenting cells for these antigens. To facilitate direct antigen presentation to CD4+ T cells, tumor cells have been transfected with syngeneic major histocompatibility complex class II, co-stimulatory molecule, and/or superantigen genes. In vivo studies in three mouse tumor models demonstrate that vaccination protects against future challenge with wild-type tumor cures some solid primary tumors, reduces established metastatic disease, and extends mean survival time. Antigen presentation studies demonstrate that in vivo vaccine efficacy is directly related to in vitro antigen presentation activity. The relevance of antigen presentation activity of the vaccines is further confirmed by in vivo studies demonstrating that during the immunization process, the vaccines directly present tumor-encoded antigens to CD4(+) T lymphocytes. Adaptation of these vaccines for the treatment of human metastatic cancers is discussed.
引用
收藏
页码:101 / 114
页数:14
相关论文
共 50 条
  • [1] Proving the principle: dendritic cell-based vaccines in urogenital cancers
    Draube, Andreas
    Klein-Gonzalez, Nela
    von Bergwelt-Baildon, Michael
    EXPERT REVIEW OF VACCINES, 2011, 10 (10) : 1355 - 1357
  • [2] Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity
    Yamaguchi, Shinjiro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    Sasakawa, Akira
    Hikita, Hayato
    Kohga, Keisuke
    Uemura, Akio
    Sakamori, Ryotaro
    Ohkawa, Kazuyoshi
    Hayashi, Norio
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (12) : 1861 - 1869
  • [3] Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity
    Shinjiro Yamaguchi
    Tomohide Tatsumi
    Tetsuo Takehara
    Akira Sasakawa
    Hayato Hikita
    Keisuke Kohga
    Akio Uemura
    Ryotaro Sakamori
    Kazuyoshi Ohkawa
    Norio Hayashi
    Cancer Immunology, Immunotherapy, 2008, 57 : 1861 - 1869
  • [4] Dendritic Cell-Based Cancer Vaccines
    Santos, Patricia M.
    Butterfield, Lisa H.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (02): : 443 - 449
  • [5] Dendritic cell-based cancer vaccines
    Bubeník, J
    FOLIA BIOLOGICA, 1999, 45 (03) : 71 - 74
  • [6] US pushes into cell-based vaccines
    不详
    TCE, 2009, (822-23): : 12 - 12
  • [7] Cell-based protein vaccines for influenza
    Cox, MMJ
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (01) : 24 - 29
  • [8] Overview of tumor cell-based vaccines
    Copier, John
    Dalgleish, Angus
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2006, 25 (5-6) : 297 - 319
  • [9] Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
    Markov, Oleg V.
    Mironova, Nadezhda L.
    Sennikov, Sergey V.
    Vlassov, Valentin V.
    Zenkova, Marina A.
    PLOS ONE, 2015, 10 (09):
  • [10] On dendritic cell-based therapy for cancers
    Onji M.
    Akbar S.M.F.
    Journal of Zhejiang University-SCIENCE B, 2005, 6 (1): : 1 - 3